TOKYO – One more Japanese company has taken a step closer to the biosimilars market through a strategic drug development alliance with a U.S. company and a drug for rheumatoid arthritis.
TOKYO – Japan is now prepared to provide drugs that could help fight the outbreak of Ebola, if the World Health Organization (WHO) or other medical workers or companies request it.
TOKYO – Japan is now prepared to provide drugs that could help fight the outbreak of Ebola, if the World Health Organization (WHO) or other medical workers or companies request it.
TOKYO – Two Japanese pharma companies are investing tens of millions into a new biotech venture fund created by Remiges Biopharma Fund LP as they look for new collaborations outside Japan.
TOKYO – A hepatitis C drug in the market in Japan since 2011 has been associated with 15 deaths in a little more than two years and with severe side effects in more than 2,500 patients, according to reports that surfaced over the weekend.
TOKYO – Two Japanese pharma companies are investing tens of millions into a new biotech venture fund created by Remiges Biopharma Fund LP as they look for new collaborations outside Japan.
TOKYO – A hepatitis C drug in the market in Japan since 2011 has been associated with 15 deaths in a little more than two years and with severe side effects in more than 2,500 patients, according to reports that surfaced over the weekend.
TOKYO – Rani Therapeutics LLC is working on a delivery system for insulin that could provide relief for millions of people who must undergo regular painful injections to deal with conditions such as diabetes, rheumatoid arthritis, osteoporosis and multiple sclerosis.
Rani Therapeutics (San Jose, California) is working on a delivery system for insulin that could provide relief for millions of people who must undergo regular painful injections to deal with conditions such as diabetes, rheumatoid arthritis, osteoporosis and multiple sclerosis.
